Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
2019
ABSTRACT Ceftazidime (CAZ) is the antibiotic of choice for the treatment of Burkholderia pseudomallei infection (melioidosis). The chromosomally-encoded PenA β-lactamase possesses weak cephalosporinase activity. The wild-type penA gene confers clinically significant CAZ resistance only when overexpressed due to a promoter mutation, transcriptional antitermination or by gene duplication and amplification (GDA). Here we characterise a reversible 33-kb GDA event involving wild-type penA in a CAZ-resistant B. pseudomallei clinical isolate from Thailand. We show that duplication arises from exchanges between short ( B. pseudomallei .
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
27
References
9
Citations
NaN
KQI